Comparison of Epigenetic and Genetic Alterations in Mucinous Cystic Neoplasm and Serous Microcystic Adenoma of Pancreas

Modern Pathology

Volumn 16, Issue 11, 2003, Pages 1086-1094

  Kim, Sang Geol ^a   Wu, Tsung Teh ^a   Lee, Jae Hyuk ^a   Yun, Young Kook ^b   Issa, Jean Pierre ^a   Hamilton, Stanley R ^a   Rashid, Asif ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Genetic alterations; Methylation; Mucinous cystic neoplasm; Pancreas; Serous microcystic adenoma

Indexed keywords

BETA CATENIN; PROTEIN P14; PROTEIN P16; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3P; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; METHYLATION; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; PANCREAS ADENOMA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOMA; CHROMOSOMES, HUMAN, PAIR 3; CYSTADENOMA, MUCINOUS; DNA METHYLATION; ENKEPHALIN, METHIONINE; GENES, P16; GENES, RAS; HELMINTH PROTEINS; HUMANS; LOSS OF HETEROZYGOSITY; MUSCLE PROTEINS; MUTATION; PANCREATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0242522859     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000094088.37888.A6     Document Type: Article

References (43)

1. Fernandez-del Castillo C, Warshaw AL. Cystic tumors of the pancreas. Surg Clin North Am 1995;75:1001-16.
2. Capella C, Solcia E, Klöppel G, Hruban RH. Serous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumors: pathology and genetics of tumors of the digestive system. Lyon, France: IARC Press; 2000. p. 231-3.
3. Zamboni G, Klöppel G, Hruban RH, Longnecker DS, Adler G. Mucinous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumors: pathology and genetics of tumors of the digestive system. Lyon, France: IARC Press; 2000. p. 234-6.
4. Solcia E, Capella C, Kloppel G. Tumors of the exocrine pancreas. In: Solcia E, Capella C, Klöppel G, editors. Atlas of tumor pathology: tumors of the pancreas. Washington, D.C.: Armed Forces Institute of Pathology; 1997. p. 31-53.
5. Klöppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 2001;1:648-55.
6. Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. Pancreatology 2001;1:641-7.
7. Wilentz RE, Albores-Saavedra J, Hruban RH. Mucinous cystic neoplasms of the pancreas. Semin Diagn Pathol 2000;17:31-42.
8. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-60.
9. Bartsch D, Bastian D, Barth P, Schudy A, Nies C, Kisker O, et al. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann Surg 1998;228:79-86.
10. Yamaguchi K, Chijiiwa K, Noshiro H, Torata N, Kinoshita M, Tanaka M. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases. Hepatogastroenterology 1999;46:2575-81.
11. Gerdes B, Wild A, Wittenberg J, Barth P, Ramaswamy A, Kersting M, et al. Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas 2003;26:42-8.
12. Jimenez RE, Warshaw AL, Z'graggen K, Hartwig W, Taylor DZ, Compton CC, et al. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg 1999;230:501-9.
13. Iacobuzio-Donahue CA, Wilentz RE, Argani P, Yeo CJ, Cameron JL, Kem SE, et al. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000;24:1544-8.
14. Ishikawa T, Nakao A, Nomoto S, Hosono J, Harada A, Nonami T, et at. Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas 1998;16:40-4.
15. Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, et al. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. Am J Pathol 2001;158:317-21.
16. Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, et al. Pancreatic involvement in von Hippel-Lindau disease: the Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000;119:1087-95.
17. Mohr VH, Vortmeyer AO, Zhuang Z, Libutti SK, Walther MM, Choyke PL, et al. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol 2000;157:1615-21.
18. Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z. Allelic deletion and mutation of the VHL tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 1997;151:951-6.
19. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
20. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med 1995;1:686-92.
21. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16 (INK4a) methylation and p53 mutational status. Cancer Res 2000;60:129-33.
22. Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, et al. Hypermethylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 2002;62:1148-51.
23. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002;160:1573-81.
24. Sato N, Ueki T, Fukushima N, Iacobuzio-Donahue CA, Yeo CJ, Cameron JL, et al. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002;123:365-72.
25. Abraham SC., Wu TT, Klimstra DS., Finn LS, Lee JH, Yeo CJ, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APG/β-catenin pathway and chromosome 11p. Am J Pathol 2001;159:1619-27.
26. Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/β-catenin pathway. Am J Pathol 2002;160:953-62.
27. Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, et al. Solid-pseudopapiUary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor β-catenin mutations. Am J Pathol 2002;160:1361-9.
28. +. Am J Pathol 1998;152:1501-7.
29. Yamamoto H, Itoh F, Nakamura H, Fukushima H, Sasaki S, Perucho M, et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001;61:3139-44.
30. Moskaluk CA, Kem SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997;150:1547-52.
31. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
32. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-42.
33. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994;91:9700-4.
34. Chan AO, Broaddus RR, Houlihan PS, Issa JP. Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002;160:1823-30.
35. Rashid A, Gao Y-T, Bhakta S, Shen M-C, Wang B-S, Deng J, et al. β-catenin mutations in bfliary tract cancers: a population-based study in China. Cancer Res 2001;61:3406-9.
36. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
37. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
38. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-30.
39. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000;60:1835-9.
40. Zhang Y, Xiong Y, Yarbrough WG, ARF promotes MDM2 degradation and stabilizes p53. ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998;92:725-34.
41. Zagon IS, Smith JP, McLaughlin PJ. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int J Oncol 1999;14:577-84.
42. Richards FM. Molecular pathology of von Hippel-Lindau disease and the VHL tumour suppressor gene. Exp Rev Mol Med 2001, available at: www-ermm.cbcu.cam.ac.uk/ 01002654h.htm
43. Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, et al. Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors. Am J Hum Genet 1997;60:765-71.